Institut de Pharmacologie et de Biologie Structurale
In research, Institut de Pharmacologie et de Biologie Structurale stands highest in Life Sciences (#2,670 of 14,347 worldwide), Biochemistry, Genetics and Molecular Biology (#2,947 of 7,814 worldwide) and Medicine (#8,622 of 17,978 worldwide), over all time.
- World rank, 2022–2025
- #9,947 of 28,054 · #6,793 all time
- Rank in France
- #354 of 1,422
- Research works
- 843 ▲ 11% vs 2013–17
- Citations
- 42k 50.0 per fractional work
- Top-10% rate
- 16.1% record average 16.5%
- Open access
- 43% world 28%
What is Institut de Pharmacologie et de Biologie Structurale known for in research?
The fields where it stands highest, over all time, ranked among every institution above the floor in each field.
| Field | World rank | Where that sits | Top-10% rate | Works |
|---|---|---|---|---|
| Life SciencesDomain | #2,670 of 14,347 | 23.2% | 504 | |
| Biochemistry, Genetics and Molecular BiologyField | #2,947 of 7,814 | 22.0% | 361 | |
| MedicineField | #8,622 of 17,978 | 30.0% | 211 | |
| Health SciencesDomain | #11,329 of 20,462 | 29.6% | 221 | |
| Molecular BiologySubfield | #2,814 of 4,961 | 19.5% | 231 |
Each strip is that field’s whole ranked pool, with the notch where Institut de Pharmacologie et de Biologie Structurale sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 12.2×. Every wedge is a field page.
- Immunology and Microbiology 12.2×
- Biochemistry, Genetics and Molecular Biology 6.1×
- Chemistry 3.6×
- Medicine 1.7×
- Veterinary 1.6×
- Pharmacology, Toxicology and Pharmaceutics 1.1×
- Neuroscience 1.1×
- Nursing 0.8×
- Agricultural and Biological Sciences 0.5×
- Materials Science 0.5×
- Decision Sciences 0.4×
- Environmental Science 0.4×
- Earth and Planetary Sciences 0.3×
- Physics and Astronomy 0.3×
- Engineering 0.2×
- Computer Science 0.2×
- Health Professions 0.1×
- Mathematics 0.1×
- Energy 0.1×
- Arts and Humanities 0.1×
- Social Sciences 0.1×
- Psychology 0.0×
- Economics, Econometrics and Finance 0.0×
Who are the top researchers at Institut de Pharmacologie et de Biologie Structurale?
Ranked on the composite score, Germain Puzo, Mamadou Daffé and Olivier Neyrolles lead among researchers whose main affiliation is Institut de Pharmacologie et de Biologie Structurale.
- 1 Germain Puzo France · #54,141 worldwide 301 citations · 30 works
- 2 Mamadou Daffé France · #54,715 worldwide 328 citations · 32 works
- 3 Olivier Neyrolles France · #57,683 worldwide 264 citations · 31 works
- 4 Martine Gilleron France · #151,707 worldwide 131 citations · 27 works
- 5 Marie‐Pierre Rols France · #156,640 worldwide 248 citations · 41 works
- 6 Isabelle Maridonneau‐Parini France · #220,501 worldwide 144 citations · 30 works
- 7 Geanncarlo Lugo‐Villarino France · #234,885 worldwide 153 citations · 19 works
- 8 Muriel Golzio France · #271,658 worldwide 110 citations · 32 works
- 9 Catherine Muller France · #297,817 worldwide 59 citations · 27 works
- 10 Bernard Monsarrat France · #310,386 worldwide 113 citations · 30 works
Which keywords describe research at Institut de Pharmacologie et de Biologie Structurale?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Treatment, Diagnosis, Epidemiology, Inflammation, Cancer, Immune Response, Vaccine and Antibiotic Resistance.
- Tandem Mass Spectrometry
- Macrophages
- Innate Lymphoid Cells
- Cancer Immunotherapy
- Proteomics
- Inflammatory Diseases
- NK Cell Recognition
- Cholesterol
- Insulin Resistance
- Gene Therapy
- Antiretroviral Therapy
- Cancer Therapy
- Nontuberculous Mycobacteria
- Tuberculosis
- Genetic Diversity
- Immunity
- Vaccine
- Immune Response
- Diagnosis
- Treatment
- Epidemiology
- Inflammation
- Cancer
- Antibiotic Resistance
- Drug Resistance
- Cystic Fibrosis
- Mycobacterium tuberculosis
- Mycobacterium avium
- Obesity
- Metabolism
- Mass Spectrometry
- Genomics
- Regulatory T Cells
- Drug Discovery
- Natural Killer Cells
- Innate Immunity
- Activation
- IL-33
- Macrophage
- Polarization
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Epidemiology12▲ 3.2×30 topics
- Treatment10▲ 8.9×16 topics
- Inflammation10▲ 4.8×36 topics
- Diagnosis10▲ 10×13 topics
- Cancer7▲ 5.7×24 topics
- Immune Response6▲ 11×10 topics
- Antibiotic Resistance5▲ 14×6 topics
- Vaccine5▲ 13×7 topics
- Drug Resistance4▲ 15×6 topics
- Immunity4▲ 11×9 topics
- Cystic Fibrosis4▲ 53×2 topics
- Genetic Diversity4▲ 8.4×3 topics
- Mycobacterium tuberculosis4▲ 66×1 topic
- Tuberculosis4▲ 70×1 topic
- Mycobacterium avium3▲ 98×1 topic
- Nontuberculous Mycobacteria3▲ 98×1 topic
- Obesity3▲ 4.1×5 topics
- Cancer Therapy3▲ 5.1×12 topics
- Metabolism3▲ 5.2×8 topics
- Antiretroviral Therapy2▲ 16×5 topics
- Mass Spectrometry2▲ 17×3 topics
- Gene Therapy2▲ 13×5 topics
- Genomics2▲ 8.0×8 topics
- Insulin Resistance2▲ 5.2×5 topics
- Regulatory T Cells2▲ 20×3 topics
- Cholesterol2▲ 15×3 topics
- Drug Discovery2▲ 9.6×6 topics
- NK Cell Recognition2▲ 32×1 topic
- Natural Killer Cells2▲ 32×1 topic
- Inflammatory Diseases2▲ 11×3 topics
- Innate Immunity2▲ 6.0×6 topics
- Proteomics2▲ 32×2 topics
- Activation2▲ 29×1 topic
- Cancer Immunotherapy2▲ 11×3 topics
- IL-332▲ 93×1 topic
- Innate Lymphoid Cells2▲ 93×1 topic
- Macrophage2▲ 25×2 topics
- Macrophages2▲ 10×3 topics
- Polarization2▲ 11×1 topic
- Tandem Mass Spectrometry2▲ 35×2 topics
Which research topics does Institut de Pharmacologie et de Biologie Structurale publish most on?
By volume in 2022–2025: Tuberculosis Research and Epidemiology, Mycobacterium research and diagnosis, Immune Cell Function and Interaction and Immune cells in cancer.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Tuberculosis Research and Epidemiology Infectious Diseases 4 works
- 2 Mycobacterium research and diagnosis Epidemiology 3 works
- 3 Immune Cell Function and Interaction Immunology 2 works
- 4 Immune cells in cancer Immunology 2 works
- 5 IL-33, ST2, and ILC Pathways Immunology 2 works
- 6 Advanced Proteomics Techniques and Applications Spectroscopy 2 works
- 7 Microbial Inactivation Methods Biotechnology 2 works
- 8 Magnetic and Electromagnetic Effects Physiology 1 works
- 9 Cancer, Lipids, and Metabolism Cancer Research 1 works
- 10 RNA and protein synthesis mechanisms Molecular Biology 1 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Institut de Pharmacologie et de Biologie Structurale's research output changed?
Output in 2018–2022 was 11% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Toulouse
- Université Toulouse III - Paul Sabatier
- Université Fédérale de Toulouse Midi-Pyrénées
- Université Toulouse - Jean Jaurès
- Institut National Polytechnique de Toulouse
- Université Toulouse-I-Capitole
- Hôpital Rangueil
- Laboratoire d'Analyse et d'Architecture des Systèmes
- Hôpital Purpan
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.